c-Myb and p300 regulate hematopoietic stem cell proliferation and differentiation - PubMed (original) (raw)
c-Myb and p300 regulate hematopoietic stem cell proliferation and differentiation
Mark L Sandberg et al. Dev Cell. 2005 Feb.
Free article
Abstract
Precise control of hematopoietic stem cell (HSC) proliferation and differentiation is needed to maintain a lifetime supply of blood cells. Using genome-wide ENU mutagenesis and phenotypic screening, we have identified a mouse line that harbors a point mutation in the transactivation (TA) domain of the transcription factor c-Myb (M303V), which reduces c-Myb-dependent TA by disrupting its interaction with the transcriptional coactivator p300. The biological consequences of the c-Myb(M303V/M303V) mutation include thrombocytosis, megakaryocytosis, anemia, lymphopenia, and the absence of eosinophils. Detailed analysis of hematopoiesis in c-Myb(M303V/M303V) mice reveals distinct blocks in T cell, B cell, and red blood cell development, as well as a remarkable 10-fold increase in the number of HSCs. Cell cycle analyses show that twice as many HSCs from c-Myb(M303V/M303V) animals are actively cycling. Thus c-Myb, through interaction with p300, controls the proliferation and differentiation of hematopoietic stem and progenitor cells.
Similar articles
- Progression through key stages of haemopoiesis is dependent on distinct threshold levels of c-Myb.
Emambokus N, Vegiopoulos A, Harman B, Jenkinson E, Anderson G, Frampton J. Emambokus N, et al. EMBO J. 2003 Sep 1;22(17):4478-88. doi: 10.1093/emboj/cdg434. EMBO J. 2003. PMID: 12941699 Free PMC article. - A transcription-factor-binding surface of coactivator p300 is required for haematopoiesis.
Kasper LH, Boussouar F, Ney PA, Jackson CW, Rehg J, van Deursen JM, Brindle PK. Kasper LH, et al. Nature. 2002 Oct 17;419(6908):738-43. doi: 10.1038/nature01062. Nature. 2002. PMID: 12384703 - Mutations in multiple domains of c-Myb disrupt interaction with CBP/p300 and abrogate myeloid transforming ability.
Pattabiraman DR, Sun J, Dowhan DH, Ishii S, Gonda TJ. Pattabiraman DR, et al. Mol Cancer Res. 2009 Sep;7(9):1477-86. doi: 10.1158/1541-7786.MCR-09-0070. Epub 2009 Sep 8. Mol Cancer Res. 2009. PMID: 19737967 - Critical roles for c-Myb in hematopoietic progenitor cells.
Greig KT, Carotta S, Nutt SL. Greig KT, et al. Semin Immunol. 2008 Aug;20(4):247-56. doi: 10.1016/j.smim.2008.05.003. Epub 2008 Jun 26. Semin Immunol. 2008. PMID: 18585056 Review. - c-Myb a stem-progenitor cell regulator in multiple tissue compartments.
Ramsay RG. Ramsay RG. Growth Factors. 2005 Dec;23(4):253-61. doi: 10.1080/08977190500233730. Growth Factors. 2005. PMID: 16338788 Review. No abstract available.
Cited by
- MYB: A Key Transcription Factor in the Hematopoietic System Subject to Many Levels of Control.
Lemma RB, Fuglerud BM, Frampton J, Gabrielsen OS. Lemma RB, et al. Adv Exp Med Biol. 2024;1459:3-29. doi: 10.1007/978-3-031-62731-6_1. Adv Exp Med Biol. 2024. PMID: 39017837 Review. - Comparative cofactor screens show the influence of transactivation domains and core promoters on the mechanisms of transcription.
Bell CC, Balic JJ, Talarmain L, Gillespie A, Scolamiero L, Lam EYN, Ang CS, Faulkner GJ, Gilan O, Dawson MA. Bell CC, et al. Nat Genet. 2024 Jun;56(6):1181-1192. doi: 10.1038/s41588-024-01749-z. Epub 2024 May 20. Nat Genet. 2024. PMID: 38769457 - Transcription Factor MYB as Therapeutic Target: Current Developments.
Klempnauer KH. Klempnauer KH. Int J Mol Sci. 2024 Mar 12;25(6):3231. doi: 10.3390/ijms25063231. Int J Mol Sci. 2024. PMID: 38542205 Free PMC article. Review. - N6-Methyladenosine RNA Modification in Normal and Malignant Hematopoiesis.
Weng H, Huang H, Chen J. Weng H, et al. Adv Exp Med Biol. 2023;1442:105-123. doi: 10.1007/978-981-99-7471-9_7. Adv Exp Med Biol. 2023. PMID: 38228961 - Epigenetic Mechanisms in Hematologic Aging and Premalignant Conditions.
Yan B, Yuan Q, Guryanova OA. Yan B, et al. Epigenomes. 2023 Dec 12;7(4):32. doi: 10.3390/epigenomes7040032. Epigenomes. 2023. PMID: 38131904 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous